Agilysys CEO exercises 45,238 restricted stock units

Agilysys President & CEO Ramesh Srinivasan exercised restricted stock units and performance-based restricted stock units into a total of 45,238 shares of common stock on March 10, 2026.

Accepted by SEC EDGAR 03/12/2026 - 04:51 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Agilysys President & CEO Ramesh Srinivasan exercised restricted stock units and performance-based restricted stock units into a total of 45,238 shares of common stock on March 10, 2026. After these equity conversions, he holds 799,884 common shares directly and 60,000 shares indirectly through the Ramesh and Sujatha Srinivasan Living Trust.

Insider Trade Summary

45,238 shares exercised/converted

Exercise 6 txns

Insider SRINIVASAN RAMESH

Role President & CEO

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	11,310	$0.00	$0.00
Exercise	Performance Restricted Stock Units	21,035	$0.00	$0.00
Exercise	Performance Restricted Stock Units	12,893	$0.00	$0.00
Exercise	Common Stock	11,310	$73.31	$829K
Exercise	Common Stock	21,035	$73.31	$1.54M
Exercise	Common Stock	12,893	$73.31	$945K
Holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units — 11,310 contracts (Direct); Performance Restricted Stock Units — 33,928 contracts (Direct); Common Stock — 799,884 shares (Direct); Common Stock — 60,000 shares (Indirect, By Ramesh and Sujatha Srinivasan Living Trust)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Agilysys (AGYS) CEO Ramesh Srinivasan report?

Agilysys CEO Ramesh Srinivasan exercised restricted and performance-based stock units into 45,238 shares of common stock. These derivative exercises increased his direct equity exposure without any reported open-market purchases or sales in this filing.

How many Agilysys (AGYS) shares does the CEO own after this Form 4?

Following the reported transactions, Ramesh Srinivasan directly owns 799,884 shares of Agilysys common stock. He also has indirect ownership of 60,000 additional shares held through the Ramesh and Sujatha Srinivasan Living Trust, as disclosed in the filing.

Were there any open-market stock sales or purchases by Agilysys (AGYS) CEO in this filing?

The Form 4 shows only derivative exercises converting restricted and performance-based units into common stock. There are no transactions coded as open-market purchases or sales, indicating the activity was equity award-related rather than discretionary market trading.

What types of equity awards did the Agilysys (AGYS) CEO exercise?

Ramesh Srinivasan exercised a mix of restricted stock units and performance restricted stock units. These awards converted into 45,238 shares of Agilysys common stock, reflecting the vesting and settlement of previously granted incentive equity rather than new market purchases.

How is the Agilysys (AGYS) CEO’s indirect ownership structured?

The filing reports 60,000 Agilysys common shares held indirectly by the Ramesh and Sujatha Srinivasan Living Trust. This indicates part of the CEO’s economic interest in the company is held through a family trust structure rather than solely in his direct name.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SRINIVASAN RAMESH

(Last) (First) (Middle)

3655 BROOKSIDE PARKWAY

SUITE 300

(Street)

ALPHARETTA GA 30022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AGILYSYS INC [ AGYS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		M		11,310	A	$73.31	765,956	D
Common Stock	03/10/2026		M		21,035	A	$73.31	786,991	D
Common Stock	03/10/2026		M		12,893	A	$73.31	799,884	D
Common Stock								60,000	I	By Ramesh and Sujatha Srinivasan Living Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	03/10/2026		M			11,310	03/10/2026	03/10/2027	Common Stock	11,310	$0	11,310	D
Performance Restricted Stock Units	$0	03/10/2026		M			21,035	03/10/2026	03/10/2027	Common Stock	21,035	$0	21,035	D
Performance Restricted Stock Units	$0	03/10/2026		M			12,893	03/10/2026	03/10/2027	Common Stock	12,893	$0	12,893	D

Explanation of Responses:

	/s/ Kyle C. Badger, Attorney-in-Fact	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.